Věra Klimešová

1.9k total citations
63 papers, 1.7k citations indexed

About

Věra Klimešová is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Věra Klimešová has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Organic Chemistry, 30 papers in Molecular Biology and 11 papers in Infectious Diseases. Recurrent topics in Věra Klimešová's work include Synthesis and biological activity (30 papers), Quinazolinone synthesis and applications (19 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (19 papers). Věra Klimešová is often cited by papers focused on Synthesis and biological activity (30 papers), Quinazolinone synthesis and applications (19 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (19 papers). Věra Klimešová collaborates with scholars based in Czechia, Slovakia and Germany. Věra Klimešová's co-authors include Karel Waisser, Jarmila Kaustová, Jan Kočı́, Ute Möllmann, Jiřı́ Kuneš, Milan Pour, Lenka Kubicová, Hans‐Martin Dahse, Jiřina Stolaříková and Kateřina Vávrová and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and International Journal of Pharmaceutics.

In The Last Decade

Věra Klimešová

62 papers receiving 1.6k citations

Peers

Věra Klimešová
S. B. Katti India
Karel Waisser Czechia
Jarmila Kaustová Czechia
Anna‐Maria Monforte Italy
Najim A. Al‐Masoudi Germany
Ashoke Sharon India
Vagolu Siva Krishna India
Giuseppe Paglietti Italy
Jiřina Stolaříková Czechia
Silvana Raić‐Malić Croatia
S. B. Katti India
Věra Klimešová
Citations per year, relative to Věra Klimešová Věra Klimešová (= 1×) peers S. B. Katti

Countries citing papers authored by Věra Klimešová

Since Specialization
Citations

This map shows the geographic impact of Věra Klimešová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Věra Klimešová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Věra Klimešová more than expected).

Fields of papers citing papers by Věra Klimešová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Věra Klimešová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Věra Klimešová. The network helps show where Věra Klimešová may publish in the future.

Co-authorship network of co-authors of Věra Klimešová

This figure shows the co-authorship network connecting the top 25 collaborators of Věra Klimešová. A scholar is included among the top collaborators of Věra Klimešová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Věra Klimešová. Věra Klimešová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Němeček, Jan, Miloslav Macháček, Markéta Benková, et al.. (2017). Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents. European Journal of Medicinal Chemistry. 130. 419–432. 29 indexed citations
2.
Karabanovich, Galina, Jan Němeček, Alejandro Carazo, et al.. (2016). S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents. European Journal of Medicinal Chemistry. 126. 369–383. 53 indexed citations
3.
Nesměrák, Karel, Andrey A. Toropov, Alla P. Toropova, et al.. (2015). Prediction of retention characteristics of heterocyclic compounds. Analytical and Bioanalytical Chemistry. 407(30). 9185–9189. 2 indexed citations
4.
Karabanovich, Galina, Jaroslav Roh, Tomáš Smutný, et al.. (2014). 1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria. European Journal of Medicinal Chemistry. 82. 324–340. 46 indexed citations
5.
Waisser, Karel, Eva Novotná, Věra Klimešová, et al.. (2010). A note to the biological activity of benzoxazine derivatives containing the thioxo group. European Journal of Medicinal Chemistry. 45(7). 2719–2725. 26 indexed citations
6.
Klimešová, Věra, et al.. (2009). Preparation and in‐vitro Evaluation of 4‐Benzylsulfanylpyridine‐2‐carbohydrazides as Potential Antituberculosis Agents. Archiv der Pharmazie. 342(7). 394–404. 7 indexed citations
7.
Beckert, Rainer, Dieter G. Weiss, Věra Klimešová, et al.. (2007). Hybrid molecules of estrone: New compounds with potential antibacterial, antifungal, and antiproliferative activities. Bioorganic & Medicinal Chemistry. 15(8). 2898–2906. 46 indexed citations
8.
Waisser, Karel, et al.. (2007). The Oriented Development of Antituberculotics (Part II): Halogenated 3‐(4‐Alkylphenyl)‐1,3‐benzoxazine‐2,4‐(3H)‐diones. Archiv der Pharmazie. 340(5). 264–267. 10 indexed citations
9.
Waisser, Karel, Jiřı́ Kuneš, Věra Klimešová, et al.. (2006). The Oriented Development of Antituberculotics: Salicylanilides. Archiv der Pharmazie. 339(11). 616–620. 30 indexed citations
10.
Waisser, Karel, et al.. (2005). Heterocyclic isosters of antimycobacterial salicylanilides. Il Farmaco. 60(5). 399–408. 19 indexed citations
11.
Klimešová, Věra, Lenka Zahajská, Karel Waisser, Jarmila Kaustová, & Ute Möllmann. (2004). Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives. Il Farmaco. 59(4). 279–288. 66 indexed citations
12.
Zahajská, Lenka, Věra Klimešová, Jan Kočı́, Karel Waisser, & Jarmila Kaustová. (2004). Synthesis and Antimycobacterial Activity of Pyridylmethylsulfanyl and Naphthylmethylsulfanyl Derivatives of Benzazoles, 1, 2, 4‐Triazole, and Pyridine‐2‐carbothioamide/‐2‐carbonitrile. Archiv der Pharmazie. 337(10). 549–555. 29 indexed citations
13.
Kazimierczuk, Zygmunt, Mariola Andrzejewska, Jarmila Kaustová, & Věra Klimešová. (2004). Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles. European Journal of Medicinal Chemistry. 40(2). 203–208. 83 indexed citations
14.
Waisser, Karel, Jiřı́ Kuneš, Milan Pour, et al.. (2003). Relationship between the Structure and Antimycobacterial Activity of Substituted Salicylanilides. Archiv der Pharmazie. 336(1). 53–71. 52 indexed citations
15.
16.
Klimešová, Věra, Karel Palát, Karel Waisser, & Jiřı́ Klimeš. (2000). Combination of molecular modeling and quantitative structure–activity relationship analysis in the study of antimycobacterial activity of pyridine derivatives. International Journal of Pharmaceutics. 207(1-2). 1–6. 17 indexed citations
17.
Waisser, Karel, et al.. (2000). New groups of antimycobacterial agents: 6-chloro-3-phenyl-4-thioxo-2 -1,3-benzoxazine-2(3 )-ones and 6-chloro-3-phenyl-2 -1,3-benzoxazine-2,4(3 )-dithiones. European Journal of Medicinal Chemistry. 35(7-8). 733–741. 69 indexed citations
18.
Waisser, Karel, Lenka Kubicová, Věra Klimešová, et al.. (1999). Relationships Between the Chemical Structure of Substances and Their Antimycobacterial Activity Against Atypical Strains. Part 18. 3-Phenyl-2H-1,3-benzoxazine-2,4(3H)-diones and Isosteric 3-Phenylquinazoline-2,4(1H,3H)-diones. Collection of Czechoslovak Chemical Communications. 64(11). 1902–1924. 19 indexed citations
19.
20.
Klimešová, Věra, et al.. (1996). Research on Antifungal and Antimycobacterial Agents. Synthesis and Activity of 4‐Alkylthiopyridine‐2‐carbothioamides. Archiv der Pharmazie. 329(10). 438–442. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. B. Katti Breakdown of academic impact, for papers by Karel Waisser Breakdown of academic impact, for papers by Jarmila Kaustová Breakdown of academic impact, for papers by Anna‐Maria Monforte Breakdown of academic impact, for papers by Najim A. Al‐Masoudi Breakdown of academic impact, for papers by Ashoke Sharon Breakdown of academic impact, for papers by Vagolu Siva Krishna Breakdown of academic impact, for papers by Giuseppe Paglietti Breakdown of academic impact, for papers by Jiřina Stolaříková Breakdown of academic impact, for papers by Silvana Raić‐Malić
Rankless by CCL
2026